NCT07084246View on ClinicalTrials.gov

Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study

Active, not recruitingOBSERVATIONAL

Enrollment

1,563

Participants

Timeline

Start Date

June 7, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Hypertension, Dyslipidemia

Trial Locations (1)

Unknown

GC Biopharma, Yŏngin

Sponsors

Lead Sponsor

GC Biopharma Corp

All Listed Sponsors

lead

GC Biopharma Corp

INDUSTRY